## Long-Term PPI Adverse Effects **Key Point:** Hypomagnesemia is the most common clinically significant adverse effect of chronic PPI use, occurring in 13–61% of long-term users. ### Mechanism of Hypomagnesemia PPIs inhibit gastric acid secretion, which is essential for: - Ionization of dietary magnesium - Absorption of Mg²⁺ in the small intestine Chronic suppression leads to: 1. Decreased gastric acid → reduced Mg²⁺ ionization 2. Impaired intestinal absorption 3. Cumulative magnesium depletion over months to years ### Clinical Consequences | Manifestation | Frequency | Clinical Significance | |---|---|---| | Asymptomatic hypomagnesemia | 13–61% | Detected on screening | | Symptomatic (muscle cramps, weakness) | 5–10% | Requires supplementation | | Cardiac arrhythmias | Rare | QT prolongation risk | | Seizures | Very rare | Severe depletion only | **Clinical Pearl:** Symptoms typically appear after 1–2 years of continuous PPI therapy. Serum magnesium should be monitored annually in patients on long-term PPIs, especially if symptomatic. **High-Yield:** Other important long-term PPI effects include: - Hypocalcemia and osteoporosis (reduced acid-dependent Ca²⁺ absorption) - Vitamin B₁₂ deficiency (impaired intrinsic factor-independent absorption) - Increased risk of *Clostridioides difficile* infection (reduced gastric acid barrier) - Hyponatremia (SIADH-like effect, rare) **Tip:** In NEET PG, when asked about "most common" long-term PPI side effect, the answer is hypomagnesemia. Acute interstitial nephritis is rare and idiosyncratic; thrombocytopenia and SBP are not PPI-related.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.